Mutations in IR gene, which reduce the number of cell-surface receptors, have been identified in patients with genetic syndromes of extreme insulin resistance (Donohue syndrome)8, suggesting that regulation of cell-surface IR levels contribute to the altered insulin signaling. This evidence concerns the gene INSR and Donohue syndrome.